Numerical decreases in total IPSS for the change from baseline to the study endpoint observed for the 2.5 mg (-4.5, p=0.201) and 5.0 mg (-4.9, p=0.062) doses of tadalafil versus the placebo (-3.8) did not reach statistical significance.
← all excerpts
Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.
1
—
—